Predicting gastric cancer risk in patients with intestinal metaplasia and atrophic gastritis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify clinical and histological factors that contribute to the development of gastric cancer in patients diagnosed with intestinal metaplasia (IM) and atrophic gastritis (AG). It employs a two-part retrospective approach, utilizing clinical data and pathology analysis to develop a machine learning algorithm for predicting future gastric cancer risks. The study will analyze data collected from a cohort of patients within the New Territories East Cluster over a 20-year period, using advanced imaging techniques for histological evaluation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults \>= 18 years of age
* Histologically proven atrophic gastritis or intestinal metaplasia (at antrum and/or body and/or angular of stomach)

Exclusion Criteria:

\- none

Where it's running

• Prince of Wales Hospital
  Shatin, New Territories, Hong Kong Recruiting

Study contacts

• Study coordinator: Felix Sia
• Email: felix.sia@cuhk.edu.hk
• Phone: +85226370428

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Monitoring patients with precursors to gastric cancer

  This study is testing the best ways to monitor people over 45 with early signs of stomach cancer to help keep them safe and healthy.

  Recruiting Instituto Portugues de Oncologia, Francisco Gentil, Porto · Porto · NCT04613570

• Registry and study on Helicobacter Pylori and related gastric conditions

  This study is trying to track how Helicobacter pylori infections affect the development of stomach problems, like pre-cancerous changes and cancer, in adults over time.

  Recruiting at 2 sites Chinese University of Hong Kong · Hong Kong and 1 other locations · NCT05053945

• Observational study on gastric precancerous conditions

  This study looks at people who are at higher risk for stomach cancer to see how conditions like atrophic gastritis and intestinal metaplasia develop over time.

  Recruiting Stanford University · Stanford, California · NCT04191551

• Breath testing for gastric cancer screening

  This study is testing if breath tests can help find gastric cancer and related conditions in people who have cancer, precancerous lesions, or are at average risk.

  Recruiting at 3 sites University of Latvia · São Paulo and 4 other locations · NCT04022109

• Preventing gastric cancer mortality through H. Pylori eradication and pepsinogen testing

  This study is testing if treating Helicobacter pylori infections and monitoring stomach health can help lower the risk of gastric cancer in middle-aged people living in high-risk areas.

  Recruiting Phase 4 International Agency for Research on Cancer · Riga · NCT02047994

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.